Fox Chase Cancer Center News

PHILADELPHIA (February 14, 2025) — Interim analysis of a clinical trial led by Fox Chase Cancer Center researchers shows promise for the treatment of patients with muscle-invasive bladder cancer.

PHILADELPHIA (February 12, 2025) — Fox Chase Cancer Center’s Johnathan Whetstine, PhD, Director of the Cancer Epigenetics Institute, recently joined the editorial board of Genes & Development, a leading, not-for-profit scientific journal that focuses on significant biological advances.

PHILADELPHIA (February 13, 2025) — Fox Chase Cancer Center is pleased to announce the hiring of Michael Noonan, DO, MS, as an Assistant Professor in the Supportive Oncology and Palliative Care Program.

PHILADELPHIA (February 10, 2024) — Jeffrey Farma, MD, FACS, Chair of the Department of Surgery at Fox Chase Cancer Center, and a team of colleagues recently published an updated review of guidelines governing the use of neoadjuvant and adjuvant therapy for patients with melanoma.

PHILADELPHIA (January 31, 2025) — Parth A. Desai, MBBS, MD, Assistant Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center, was recently awarded the 2024 Innovation Award by Ride Hard Breathe Easy, which helps raise awareness and funds for patients being treated for lung cancer.

PHILADELPHIA (January 31, 2025) — Lilian J. Shin-Cho, PhD, an Assistant Professor in the Cancer Prevention and Control Research Program at Fox Chase Cancer Center, was recently selected as an American Psychosocial Oncology Society (APOS) 2025 Health Equity Scholar.

PHILADELPHIA (January 31, 2025) — Eric Goodlev, MD, an Associate Professor in the Supportive Oncology and Palliative Care Program at Fox Chase Cancer Center, was recently named a Fellow of the American Academy of Hospice and Palliative Medicine (AAHPM).

PHILADELPHIA (January 29, 2025) — Austin D. Williams, MD, MSEd, FACS, Assistant Professor in the Division of Breast Surgery within the Department of Surgery at Fox Chase Cancer Center, was recently named a Presidential Scholar by the Society of Surgical Oncology (SSO).